M. Gopinath – författare

Antimicrobial Resistance and Its Consequences on the Global Economy: Progress towards Attaining the Sustainable Development Goals examines the threat that antimicrobial resistance (AMR) poses to public health, considering its impact upon prolonged illnesses, increased healthcare costs, and higher mortality rates.The book begins with an introduction to the global challenges of AMR before exploring the profound economic repercussions and the role of various sectors, including the pharmaceutical industry, agricultural practices, and food production. It also discusses ethical considerations in tackling AMR, as well as biotechnological and integrative approaches to AMR management. International responses and experiences in low- and middle-income countries are covered, in addition to the Sustainable Development Goals and future directions and recommendations. By promoting responsible antibiotic use, enhancing surveillance systems, and investing in the research and development of new antimicrobial agents, this book aims to preserve the effectiveness of existing treatments and safeguard public health for future generations.Through detailed case studies, policy recommendations, and innovative solutions, Antimicrobial Resistance and Its Consequences on the Global Economy serves as an essential resource for professionals working across microbiology, healthcare, agriculture, and related fields, equipping them with the knowledge and tools needed to implement effective AMR management practices. It also serves as a valuable resource for students across these areas, fostering a new generation of experts dedicated to preserving the efficacy of antimicrobial treatments and combating AMR effectively. - Presents actionable strategies for healthcare, agriculture, and policy sectors to combat AMR effectively- Delivers a multidisciplinary approach, with relevance to researchers working across a range of fields, including healthcare, agriculture, sustainability, and food production- Highlights innovative research and development in new antimicrobial agents and technologies